Effects of Cognitive-motor Training on Cognition, Depression and Daily Functioning in Patients With Mild Cognitive Impairment (MCI) - Trial NCT06313931
Access comprehensive clinical trial information for NCT06313931 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad de Zaragoza and is currently Completed. The study focuses on Mild Cognitive Impairment. Target enrollment is 26 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Universidad de Zaragoza
Timeline & Enrollment
N/A
Jul 03, 2023
Sep 14, 2023
Primary Outcome
Spanish version of the Montreal Cognitive Assessment (MoCA-S),Short Geriatric Depression Scale (SGDS-S),Instrumental Activities of Daily Living Scale (IADL-S)
Summary
This randomized controlled trial evaluated the effectiveness of an immersive virtual reality
 (IVR) application (focused on a daily activity) to train cognitive functions and its impact
 on depression and the ability to perform activities of daily living (ADL) in patients with
 mild cognitive impairment (MCI). With a dose of two sessions per week during six weeks, the
 study showed significant improvements in cognitive functions and reduction in depression,
 with notable effects in the experimental group. This underscores the potential of IVR as a
 valuable tool in the management of MCI.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06313931
Device Trial